Toomey Announces $1 Million Federal PFAS Study in Montgomery County
Washington, D.C. - The Centers for Disease Control and Prevention (CDC) has announced it is awarding $1 million to RTI International and the Pennsylvania Department of Health to study PFAS exposure in Montgomery County, Pa.
This study, originally authorized by a provision that Senator Toomey supported in the FY2018 National Defense Authorization Act (NDAA), is one of seven health studies around the country that will expand the science about the relationships between PFAS exposure and certain health outcomes and it will help people better understand their risk for health effects.
"I share my constituents' concerns regarding water contamination from PFAS chemicals, and I am glad the CDC is focusing its attention on southeast Pennsylvania by choosing Montgomery County as a site for this health study," said Senator Toomey. "With this study, the EPA's Action Plan, and the bipartisan amendment Senator Casey and I successfully included in the Senate-passed FY2020 NDAA, I am hopeful the residents of Bucks and Montgomery Counties will soon have answers about any risks associated with PFAS exposure."
Background (Courtesy of CDC)
Last April, the CDC's Agency for Toxic Substances and Disease Registry (ATSDR) solicited research proposals for the PFAS multi-site health study, a study that will look at the relationship between PFAS exposure and certain health outcomes.
The multi-site health study will expand the science about the relationships between PFAS exposure and certain health outcomes and it will help people better understand their risk for health effects. The study will look at many specific health endpoints, such as lipid metabolism, kidney function, thyroid disease, liver disease, glycemic parameters and diabetes, as well as immune response.
The multi-site study seeks to enroll 6000 adults and 2000 children across all sites. At each site, the core research activities will focus on assessing health outcomes among adults and children exposure to PFAS-contaminated drinking water. The information about the relationship between PFAS exposure and health outcomes will allow communities and governmental agencies to make better decisions about how to protect public health. It will also better prepare individuals to follow up with health care providers and monitor their health.
More information about the multi-site study is available on CDC/ATSDR's website, and information about CDC/ATSDR's other activities to address PFAS exposure can be found at www.atsdr.cdc.gov/pfas.